An <i>in situ</i> grown ultrathin and robust protein nanocoating for mitigating thromboembolic issues associated with cardiovascular medical devices-Reference-Cited by-同舟云学术

An in situ grown ultrathin and robust protein nanocoating for mitigating thromboembolic issues associated with cardiovascular medical devices

Published:2023 Issue:23 Volume:11 Page:7655-7662
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Miao Bianliang¹,Liu Yi¹,Zhang Along²,Cao Ye²,Zhong Rui²,Liu Jiaxin²,Shao Zhengzhong¹^ORCID

Affiliation:

1. State Key Laboratory of Molecular Engineering of Polymers, Laboratory of Advanced Materials and Department of Macromolecular Science, Fudan University, Shanghai 200433, China

2. Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China

Abstract

Protein ultrathin nanocoatings are fabricated in situ based on the interfacial cooperative assembly of silk fibroin and lysozyme. This nanocoating enhances the hemocompatibility of materials and mitigating thromboembolic issues.

Funder

Chinese Academy of Medical Sciences Initiative for Innovative Medicine

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/BM/D3BM01188G

Reference44 articles.

1. Ultrathin and Robust Hydrogel Coatings on Cardiovascular Medical Devices to Mitigate Thromboembolic and Infectious Complications

2. The Risk of Bloodstream Infection in Adults With Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies

3. Medical device-induced thrombosis: what causes it and how can we prevent it?

4. Complications with peripherally inserted central catheters (PICCs) used in hospitalized patients and outpatients: a prospective cohort study

5. Complication and Failures of Central Vascular Access Device in Adult Critical Care Settings*